Lung cancer begins in the lungs and has become the leading cause of cancer deaths in the United States for both men and women--claiming more lives than colon, ovarian, prostate, and breast cancer combined. There are two types of lung cancer: small and non-small based on the appearance of the cancer cells on the microscope. Risk for being diagnosed with lung cancer includes smoking, second hand smoke, exposure to radon gas, asbestos, and other chemicals, excessive alcohol use, and a family history. Treatments depend on the stage as well as type of lung cancer but include: surgery, chemotherapy, radiation, targeted drug therapy, and clinical trials. Stage IV lung cancer is the most aggressive cancer and occurs when the cancer is in both lungs, the fluid around the lungs, and in distant sites such as other organs. This is the most progressed stage of lung cancer.
Stage Iv Lung Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iv Lung Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1599 products for the study of Stage Iv Lung Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.